Moleculin Biotech Stock Forecast

MBRX's stock price has decreased by -90.34% in the past year and price targets may not have had time to catch up.

Stock Price Forecast

The 2 analysts with 12-month price forecasts for Moleculin Biotech stock have an average target of 61, with a low estimate of 22 and a high estimate of 100. The average target predicts an increase of 2,282.81% from the current stock price of 2.56.

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$22	$61	$100	$100
Change	+759.38%	+2282.8%	+3806.3%	+3806.3%

* Price targets were last updated on Mar 24, 2026.

Analyst Ratings

The average analyst rating for Moleculin Biotech stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Nov '25	Dec '25	Jan '26	Feb '26	Mar '26	Apr '26
Strong Buy	4	4	4	4	4	2
Buy	0	0	0	0	0	0
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	4	4	4	4	4	2

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Sara Nik HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $22	Strong Buy	Reiterates	$22	+759.38%	Mar 24, 2026
Sara Nik HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Maintains $4 → $22	Strong Buy	Maintains	$4 → $22	+759.38%	Dec 11, 2025
Sara Nik HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $100	Strong Buy	Reiterates	$100	+3,806.25%	Sep 10, 2025
Sara Nik HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $100	Strong Buy	Reiterates	$100	+3,806.25%	Aug 27, 2025
Joseph Pantginis HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $100	Strong Buy	Reiterates	$100	+3,806.25%	Jun 18, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

Revenue Next Year

n/a

EPS This Year

-5.08

from -28.42

EPS Next Year

-3.92

from -5.08

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	-	-	-	-	-	-	-
Revenue Growth	-	-	-	-	-	-	-
EPS	-221.77	-380.52	-376.71	-189.14	-28.42	-5.08	-3.92
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	5	5

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027
High	n/a	n/a
Avg	n/a	n/a
Low	n/a	n/a

Revenue Growth

Revenue Growth	2026	2027
High	-	-
Avg	-	-
Low	-	-

EPS Forecast

EPS	2026	2027
High	-4.40	-3.21
Avg	-5.08	-3.92
Low	-5.48	-4.77

EPS Growth

EPS Growth	2026	2027
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.